References
Poon RT, Fan ST, Wong J, et al. Clinical implications of circulating angiogenic factor in cancer patients. J Clin Oncol 2001;19:1207–25.
Gasparini G, Toi M, Gion M, et al. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J Natl Cancer Inst 1997;89:139–47.
Vincenti V, Cassano C, Roschi M, Persico G. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 1996;93:1493–95.
Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Haas J, Samonigg H. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 2003;106:468–71.
Kataoka N, Cai Q, Wen W, Shu XO, Jin F, Gao YT, Zheng W. Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women. Cancer Epidemiol Biomarkers Prev 2006;15:1148–52.
Jin Q, Hemminki K, Enquist K, Lenner P, et al. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res 2005;11:3647–53.
Jacobs EJ, Feigelson HS, Bain EB, Brady KA, Rodriguez C, Stevens VL, Patel AV, Thun MJ, Calle EE. Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the cancer prevention study II cohort. Breast Cancer Res 2006;8:R22.
Howell WM, Bateman AC, Turner SJ, Collins A, Theaker JM. Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma. Genes Immun 2002;3:229–32.
Lee SJ, Lee SY, Jeon HS, et al. Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 2005;14:571–5.
Sfar S, Hassen E, Saad H, Mosbah F, Chouchane L. Association of VEGF genetic polymorphism with prostate carcinoma risk and clinical outcome. Cytokine 2006;35:21–8.
Renner W, Kotschan S, Hoffman C, Obermayer-Pietsch B, Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 2000;37:443–8.
Eroglu A, Gulec S, Kurtman C, Cam R, Akar N. Vascular endothelial growth factor 936 C/T polymorphism in cancer patients. Ann Oncol 2006;17:1467–68.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eroğlu, A., Öztürk, A., Çam, R. et al. Vascular endothelial growth factor gene 936 C/T polymorphism in breast cancer patients. Med Oncol 25, 54–55 (2008). https://doi.org/10.1007/s12032-007-0046-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12032-007-0046-4